Investing.com - Avidity Bio (NASDAQ: RNA) reported third quarter EPS of $-0.65, $0.06 better than the analyst estimate of $-0.71. Revenue for the quarter came in at $2.34M versus the consensus estimate of $4.07M.
Avidity Bio's stock price closed at $47.48. It is up 1.13% in the last 3 months and up 776.01% in the last 12 months.
Avidity Bio saw 6 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Avidity Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Avidity Bio's Financial Health score is "fair performance".
Check out Avidity Bio's recent earnings performance, and Avidity Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar